WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation - Related Studies

WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation (WIN)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2011 by University Hospital Southampton NHS Foundation Trust..
Recruitment status was Recruiting

Study NCT01334060 Information provided by University Hospital Southampton NHS Foundation Trust.

First Received on April 11, 2011. Last Updated on May 17, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Leukaemia (Acute)
Leukaemia (Chronic)
Leukaemia (Acute Myeloid)
Leukaemia (Acute Lymphoblastic)
Leukaemia (Acute Promyelocytic)

Additional conditions recognized in this trial

Hematologic Neoplasms
Leukemia

More general conditions related to this trial

Hematologic Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site

Additional drug interventions recognized in this trial

2,5-Dimethoxy-4-Methylamphetamine

More general drug interventions related to this trial

Central Nervous System Agents
Hallucinogens
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Receptor Agonists
Therapeutic Uses

Sponsors listed in this trial

University Hospital Southampton NHS Foundation Trust.
Imperial College Healthcare NHS Trust
Royal Devon and Exeter NHS Foundation Trust
Inovio Pharmaceuticals
Efficacy and Mechanism Evaluation ( EME ) programme
Leukemia Research Fund